As 2022 starts I'd like to wish you all a Happy New Year and hope that 2022 marks the start of the recovery from the pandemic.

The Drug Discovery Resources website continues to increase in popularity with 193,322 page views, an increase of 31% over the figure for 2020. The pages were visited by over 95,308 viewers and around 20% of the visitors come back on multiple occasions suggesting they find it useful. The visitors come from 180 different countries with the top countries being

• United States (25%)
• United Kingdom (14%)
• India (13%)
• Germany (3.6%)
• Canada (3%)
• South Korea (2.5%)

Perhaps not unexpectedly one of the popular pages was COVID-19 and the Identification of "Drug Candidates" a checklist for those using virtual screening to identify potential hits for COVID-19 targets.

The other most viewed pages were

• Lipophilicity
• Bioisosteres
• Distribution and Plasma Protein Binding
• Molecular Interactions
• Kinase Inhibitors
• Acid Bioisosteres
• Aromatic Bioisosteres
• Aspartic Acid Proteases
• Solvation and desolvation
• HERG Activity
• Fragment based screening
• ADME

Looking at the operating systems 54% are Windows users, 20% Mac users, 13% Android, 9% iOS and 2% Linux.

I don't know how comprehensive the analytics software is but there is approximately a 50:50 M:F split for Gender.